[Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
Zabolotskikh
I B
IB
Sin'kov
S V
SV
Klevko
V A
VA
D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D002763:Cholecystectomy; D017984:Enoxaparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007044:Hysterectomy; D008297:Male; D015337:Multicenter Studies as Topic; D009104:Multiple Trauma / Q000601:surgery; D009369:Neoplasms / Q000601:surgery; D009985:Orthopedics; D011183:Postoperative Complications / Q000517:prevention & control*; D011468:Prostatectomy; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control*; D013997:Time Factors
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D017984:Enoxaparin; D005343:Fibrinolytic Agents; D006493:Heparin